Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 10—October 2009

CME ACTIVITY

Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA

Philip Van De Griend, Loreen A. HerwaldtComments to Author , Bret Alvis, Mary DeMartino, Kristopher Heilmann, Gary Doern, Patricia Winokur, Diana DeSalvo Vonstein, and Daniel Diekema
Author affiliations: The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA (P. Van De Griend, L.A. Herwaldt, B. Alvis, K. Heilmann, G. Doern, P. Winokur, D. Diekema); The University of Iowa Hygienic Lab, Iowa City (M. DeMartino); The University of Iowa College of Public Health, Iowa City (L.A. Herwaldt); The University of Iowa Hospitals and Clinics, Iowa City (L.a. Herwaldt, D. Diekema); The Iowa City Veterans Administration Medical Center, Iowa City (P. Winokur, D.D. Vonstein, D. Diekema)

Main Article

Table 3

Antimicrobial drug susceptibility of 54 invasive MRSA USA300/400 isolates, Iowa, USA, 2006*

Antimicrobial agent % Susceptible
Erythromycin 9
Levofloxacin 57
Clindamycin† 93
Tetracycline 93
Mupirocin 98
Rifampin 98
Trimethoprim/sulfamethoxazole 100
Vancomycin 100
Gentamicin 100
Daptomycin 100
Linezolid 100

*MRSA, methicillin-resistant Staphylococcus aureus.
†Includes D-testing of all erythromycin-resistant, clindamycin-susceptible isolates.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO